Landscape Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,157
Closed -$323K 788
2023
Q4
$323K Buy
+5,157
New +$323K 0.03% 551